#abbvie

2 briefings

AbbVie Buys Apogee Therapeutics for $10.9B After Years of Courtship

Jul 7, 2026, 12:13 AM

AbbVie Bets $10.9B on Apogee in Bid to Reload Its Immunology Pipeline

Jun 22, 2026, 5:08 PM